Keyphrases
ADAM9
25%
Apocrine Carcinoma
100%
Basal Cell Markers
25%
BRCA2
25%
Breast Cancer Susceptibility Gene 1 (BRCA1)
25%
Breast Carcinoma
100%
Caveolin-1 (Cav-1)
25%
CDH1
25%
CK14
25%
Complex Phenotypes
25%
Cyclin D1 (CCND1)
50%
E-cadherin Expression
25%
Fluorescence in Situ Hybridization
50%
Functional Studies
25%
Gene Copy number
50%
Genetic Modification
50%
HER2-positive
50%
Human Epidermal Growth Factor Receptor 2 (HER2)
75%
Immunohistochemical Profiling
100%
Immunohistochemistry
75%
Invasive Apocrine Carcinoma
25%
Ki-67
25%
Molecular Classification
25%
Molecular Genetic Characteristics
25%
Molecular Genetics
50%
Molecular Mechanism
25%
Molecular Profiling
100%
Molecular Targets
25%
Mucin 1 (MUC1)
25%
Multiplex Ligation-dependent Probe Amplification
75%
Next-generation Sequencing
50%
Overexpression
25%
Phosphohistone H3
25%
PI3KCA
25%
Proliferation Activity
25%
Promising Biomarkers
25%
PTEN Gene
25%
TRAF4
25%
Tumor Protein p53 (TP53)
25%
Unsupervised Cluster Analysis
25%
ZNF703
25%
Biochemistry, Genetics and Molecular Biology
ADAM9
33%
BRCA1
33%
BRCA2
33%
Cadherin
33%
Caveolin 1
33%
Cell Marker
33%
Cluster Analysis
33%
Cyclin D1
33%
Epidermal Growth Factor Receptor
33%
Fluorescence in Situ Hybridization
66%
Gene Mutation
66%
Genetic Trait
33%
KRAS
33%
Molecular Genetics
100%
Morphology
33%
Multiplex Ligation-Dependent Probe Amplification
100%
Next Generation Sequencing
66%
PTEN (Gene)
33%
TOP2A
66%
TRAF4
33%